[Urinary exploration of metabolism: nutrition assessment, urolithiasis and tubulopathy].

Exploration urinaire du métabolisme : bilan nutritionnel, lithiase urinaire et tubulopathie.

Journal

Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 22 1 2020
Statut: ppublish

Résumé

The SFBC working group aimed to deal with biological tests outside the french nomenclature that may be useful in the context of urinary exploration of metabolism. This section will be divides into three parts: 1) nutritional assessment using urinary urea; 2) metabolic assessment of urolithiasis; 3) exploration of tubulopathies. National and international recommendations support the evaluation of nutritional status from urea measurements in urine and dialysate with the following indications: primary metabolic evaluation of urolithiasis patients, monitoring of protein intake in chronic renal failure stage 3 or stage 5D with residual diuresis. For the management of the urolithiasis disease, biomedical tests recommended by the national and international guidelines are the measurement of the urinary density using refractometry in the primary metabolic evaluation as well as the determination of oxalemia in the diagnosis (patients with GFR< 30 mL/min/1.73 m

Identifiants

pubmed: 31418699
pii: abc.2019.1458
doi: 10.1684/abc.2019.1458
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

381-389

Auteurs

Christelle Machon (C)

Hospices civils de Lyon, Centre hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, Pierre Bénite, France.

Anne-Sophie Bargnoux (AS)

Laboratoire de biochimie, PhyMedExp, Université de Montpellier, Inserm, CNRS, CHU de Montpellier, France.

Yann Barguil (Y)

Laboratoire de biochimie -toxicologie, Centre hospitalier territorial Gaston-Bourret, Nouméa, Nouvelle-Calédonie.

Stéphanie Baron (S)

Assistance Publique-Hôpitaux de Paris (AP-HP) Georges Pompidou European Hospital, Physiology Department ; Paris-Descartes University ; Inserm UMRS 1138 - CNRS ERL 8228, Paris, France.

Jean-Paul Cristol (JP)

Laboratoire de biochimie, PhyMedExp, Université de Montpellier, Inserm, CNRS, CHU de Montpellier, France.

Vincent Frochot (V)

Sorbonne Université, Inserm, UMR_S 1155, AP-HP, Hôpital Tenon, Paris ; Service d'explorations fonctionnelles multidisciplinaires, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Tenon, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH